Paradoxes of cancer: Survival at the brink

Semin Cancer Biol. 2022 Jun:81:119-131. doi: 10.1016/j.semcancer.2020.12.009. Epub 2020 Dec 16.

Abstract

The fundamental understanding of how Cancer initiates, persists and then progresses is evolving. High-resolution technologies, including single-cell mutation and gene expression measurements, are now attainable, providing an ever-increasing insight into the molecular details. However, this higher resolution has shown that somatic mutation theory itself cannot explain the extraordinary resistance of cancer to extinction. There is a need for a more Systems-based framework of understanding cancer complexity, which in particular explains the regulation of gene expression during cell-fate decisions. Cancer displays a series of paradoxes. Here we attempt to approach them from the view-point of adaptive exploration of gene regulatory networks at the edge of order and chaos, where cell-fate is changed by oscillations between alternative regulators of cellular senescence and reprogramming operating through self-organisation. On this background, the role of polyploidy in accessing the phylogenetically pre-programmed "oncofetal attractor" state, related to unicellularity, and the de-selection of unsuitable variants at the brink of cell survival is highlighted. The concepts of the embryological and atavistic theory of cancer, cancer cell "life-cycle", and cancer aneuploidy paradox are dissected under this lense. Finally, we challenge researchers to consider that cancer "defects" are mostly the adaptation tools of survival programs that have arisen during evolution and are intrinsic of cancer. Recognition of these features should help in the development of more successful anti-cancer treatments.

Keywords: Aneuploidy; Bivalency; Cancer atavism; Cancer “life-cycle”; Reversible polyploidy; Self-organisation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aneuploidy
  • Cellular Senescence / genetics
  • Gene Regulatory Networks
  • Humans
  • Neoplasms* / genetics
  • Polyploidy*